Portage invests in Stimunity SA, a Paris-based cancer immunotherapy company – PR Newswire (press release)
|
Portage invests in Stimunity SA, a Paris-based cancer immunotherapy company
PR Newswire (press release) TORONTO, Feb. 28, 2018 /PRNewswire/ – Portage Biotech Inc. ("Portage" or "the Company") (Canadian Securities Exchange: PBT.U, OTC Markets : PTGEF), is pleased to announce that it has made an investment in Stimunity, SAS ("Stimunity"), a Paris-based … |
